2026-06-14T03:50:54Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/200982024-11-28T19:30:04Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Gayoso, Jorge author Balsalobre, Pascual author Kwon, Mi author Castilla-Llorente, Cristina author Jesus Pascual, Maria author Lopez-Corral, Lucia author Luis Pinana, Jose author Bermudez, Arancha author Antonio Perez-Simon, Jose author Herrera, Pilar author Montesinos, Pau author Ferra, Christelle author Sampol Mayol, Antonia author Anguita, Javier author Heras, Inmaculada author Champ, Diana author Martinez-Laperche, Carolina author Solano, Carlos author Caballero, Dolores author Luis Diez-Martin, Jose author 2015-02 Gayoso J, Balsalobre P, Kwon M, Castilla-Llorente C, Jesus Pascual M, Lopez-Corral L, et al. Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results [meeting abstract]. Biol Blood Marrow Transplant. 2015 Feb;21(Suppl 2):S284. 10.1016/j.bbmt.2014.11.450 1523-6536 1083-8791 Biology of Blood and Marrow Transplantation http://hdl.handle.net/20.500.13003/17322 http://hdl.handle.net/20.500.12105/20098 348633000406 Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with Post-Transplant Cyclophosphamide (PT-CY) As Gvhd Prophylaxis in High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results